Diluting Fluid A: Intended Use
Diluting Fluid A: Intended Use
Diluting Fluid A: Intended Use
Intended use
Recommended as Diluent in testing of pharmaceuticals in accordance with USP .
Composition**
Ingredients Gms / Litre
Peptone 1.000
Final pH ( at 25°C) 7.1±0.2
**Formula adjusted, standardized to suit performance parameters
Directions
Diluting fluid is used as the diluting or rinsing solution for membrane filter techniques in pharmaceutical products. Measured
portions of Diluting fluid A should be used to rinse the membrane after filtration. Inoculate this rinse with 50-100 cfu of test
organisms. Simultaneously run a positive control of the same medium. Incubate both the set of medium at the specified time
and temperature. Compare the growth obtained for the rinse with that obtained in the positive control after incubation.
Limitations
1. Further biochemical and serological testing must be carried out for complete identification.
pH
6.90-7.30
Sterility test
Passes release criteria.
Growth Promotion Test
In accordance with the harmonized method of USP.
Cultural Response
Cultural characteristics observed after an incubation at 35-37°C for 24-48 hours
Organism Inoculum Growth
(CFU)
Candida albicans ATCC 50-100 good
10231 (00054*)
Escherichia coli ATCC 50-100 good
25922 (00013*)
Staphylococcus aureus 50-100 good
subsp. aureus ATCC
25923 (00034*)
Staphylococcus aureus 50-100 good
subsp. aureus ATCC
6538 (00032*)
Key: (*) Corresponding WDCM Numbers
Disposal
User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow
established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical
sample must be decontaminated and disposed of in accordance with current laboratory techniques (1,2).
Reference
1. Isenberg, H.D. Clinical Microbiology Procedures Handbook. 2nd Edition.
2. Jorgensen,J.H., Pfaller , M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015)
Manual of Clinical Microbiology, 11th Edition. Vol. 1.
3.The United States Pharmacopoeia , 2019, US Pharmacopeial convention Inc., Rockville,MD.
Revision : 00 / 2019
Disclaimer :
User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained in
this and other related HiMedia™ publications. The information contained in this publication is based on our research and development
work and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes to
specifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use but
for laboratory,diagnostic,research or further manufacturing use only, unless otherwise specified. Statements contained herein should not
be considered as a warranty of any kind, expressed or implied, and no liability is accepted for infringement of any patents.
HiMedia Laboratories Pvt. Ltd. Reg.office : 23, Vadhani Ind.Est., LBS Marg, Mumbai-400086, India. Customer care No.: 022-6116 9797 Corporate office :
A-516,Swastik Disha Business Park,Via Vadhani Ind. Est., LBS Marg, Mumbai-400086, India. Customer care No.: 022-6147 1919 Email:
[email protected] Website: www.himedialabs.com